MetLife Investment Management LLC Boosts Stake in Hamilton Lane Incorporated (NASDAQ:HLNE)

MetLife Investment Management LLC lifted its position in Hamilton Lane Incorporated (NASDAQ:HLNE) by 89.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,959 shares of the company’s stock after acquiring an additional 19,810 shares during the period. MetLife Investment Management LLC owned 0.08% of Hamilton Lane worth $7,065,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Van Berkom & Associates Inc. raised its holdings in Hamilton Lane by 2.0% in the second quarter. Van Berkom & Associates Inc. now owns 892,812 shares of the company’s stock worth $110,334,000 after purchasing an additional 17,272 shares in the last quarter. Copeland Capital Management LLC increased its stake in shares of Hamilton Lane by 0.8% in the 3rd quarter. Copeland Capital Management LLC now owns 863,397 shares of the company’s stock worth $145,388,000 after acquiring an additional 7,106 shares in the last quarter. Fred Alger Management LLC lifted its position in Hamilton Lane by 10.5% during the 2nd quarter. Fred Alger Management LLC now owns 687,521 shares of the company’s stock valued at $84,964,000 after acquiring an additional 65,151 shares during the period. Dimensional Fund Advisors LP boosted its stake in Hamilton Lane by 6.8% during the second quarter. Dimensional Fund Advisors LP now owns 590,270 shares of the company’s stock worth $72,943,000 after acquiring an additional 37,680 shares in the last quarter. Finally, Principal Financial Group Inc. grew its holdings in Hamilton Lane by 20.2% in the third quarter. Principal Financial Group Inc. now owns 583,721 shares of the company’s stock worth $98,297,000 after purchasing an additional 97,924 shares during the period. Hedge funds and other institutional investors own 97.40% of the company’s stock.

Hamilton Lane Stock Up 0.2 %

HLNE stock opened at $192.40 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 3.37. Hamilton Lane Incorporated has a 1-year low of $96.38 and a 1-year high of $203.72. The stock has a market capitalization of $10.66 billion, a P/E ratio of 41.74 and a beta of 1.18. The business has a fifty day moving average price of $181.47 and a 200-day moving average price of $150.44.

Hamilton Lane (NASDAQ:HLNE) last issued its earnings results on Wednesday, November 6th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.01. The business had revenue of $150.00 million during the quarter, compared to analyst estimates of $151.55 million. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. Hamilton Lane’s revenue was up 18.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.89 EPS. Equities analysts forecast that Hamilton Lane Incorporated will post 4.87 earnings per share for the current fiscal year.

Hamilton Lane Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 7th. Investors of record on Monday, December 16th will be given a dividend of $0.49 per share. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.96 dividend on an annualized basis and a yield of 1.02%. Hamilton Lane’s dividend payout ratio (DPR) is 42.52%.

Analysts Set New Price Targets

A number of analysts have recently commented on HLNE shares. Wells Fargo & Company boosted their price target on Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 9th. Morgan Stanley boosted their target price on Hamilton Lane from $182.00 to $190.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. Keefe, Bruyette & Woods raised their price target on Hamilton Lane from $181.00 to $215.00 and gave the company a “market perform” rating in a report on Thursday, November 7th. UBS Group lifted their price target on Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 22nd. Finally, The Goldman Sachs Group increased their price objective on shares of Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Seven equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $180.33.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.